156 related articles for article (PubMed ID: 6202101)
21. Aggregative adherence of uropathogenic Proteus mirabilis to cultured epithelial cells.
Rocha SP; Elias WP; Cianciarullo AM; Menezes MA; Nara JM; Piazza RM; Silva MR; Moreira CG; Pelayo JS
FEMS Immunol Med Microbiol; 2007 Nov; 51(2):319-26. PubMed ID: 17714491
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-8 response in cells from the human urinary tract induced by lipopolysaccharides of Proteus mirabilis O3 and O18.
Chromek M; Stankowska D; Dadfar E; Kaca W; Rabbani H; Brauner A
J Urol; 2005 Apr; 173(4):1381-4. PubMed ID: 15758809
[TBL] [Abstract][Full Text] [Related]
23. Uptake pathways of clinical isolates of Proteus mirabilis into human epithelial cell lines.
Oelschlaeger TA; Tall BD
Microb Pathog; 1996 Jul; 21(1):1-16. PubMed ID: 8827702
[TBL] [Abstract][Full Text] [Related]
24. Uropathogenic properties of Proteus mirabilis and Proteus vulgaris.
Peerbooms PG; Verweij AM; MacLaren DM
J Med Microbiol; 1985 Feb; 19(1):55-60. PubMed ID: 3881591
[TBL] [Abstract][Full Text] [Related]
25. Allicin from garlic inhibits the biofilm formation and urease activity of Proteus mirabilis in vitro.
Ranjbar-Omid M; Arzanlou M; Amani M; Shokri Al-Hashem SK; Amir Mozafari N; Peeri Doghaheh H
FEMS Microbiol Lett; 2015 May; 362(9):. PubMed ID: 25837813
[TBL] [Abstract][Full Text] [Related]
26. Properties of a deep Proteus R mutant isolated from clinical material.
Krajewska-Pietrasik D; Rózalski A; Bartodziejska B; Radziejewska-Lebrecht J; Mayer H; Kotełko K
APMIS; 1991 Jun; 99(6):499-506. PubMed ID: 2054167
[TBL] [Abstract][Full Text] [Related]
27. Haemagglutination, haemolysin production and serum resistance of proteus and related species isolated from clinical sources.
Mishra M; Thakar YS; Pathak AA
Indian J Med Microbiol; 2001; 19(2):5-11. PubMed ID: 17664798
[TBL] [Abstract][Full Text] [Related]
28. [Etiological and molecular characteristics of diarrhea caused Proteus mirabilis].
Shi X; Hu Q; Lin Y; Qiu Y; Li Y; Jiang M; Chen Q
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Jun; 35(6):724-8. PubMed ID: 25174481
[TBL] [Abstract][Full Text] [Related]
29. Visualization of Proteus mirabilis within the matrix of urease-induced bladder stones during experimental urinary tract infection.
Li X; Zhao H; Lockatell CV; Drachenberg CB; Johnson DE; Mobley HL
Infect Immun; 2002 Jan; 70(1):389-94. PubMed ID: 11748205
[TBL] [Abstract][Full Text] [Related]
30. Proteus mirabilis Overview.
Mobley HLT
Methods Mol Biol; 2019; 2021():1-4. PubMed ID: 31309490
[TBL] [Abstract][Full Text] [Related]
31. Co-ordinate expression of virulence genes during swarm-cell differentiation and population migration of Proteus mirabilis.
Allison C; Lai HC; Hughes C
Mol Microbiol; 1992 Jun; 6(12):1583-91. PubMed ID: 1495387
[TBL] [Abstract][Full Text] [Related]
32. Swarmer cell differentiation in Proteus mirabilis.
Rather PN
Environ Microbiol; 2005 Aug; 7(8):1065-73. PubMed ID: 16011745
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of motility and adherence of Proteus mirabilis to uroepithelial cells by subinhibitory concentrations of amikacin.
Tawfik AF; Ramadan MA; Shibl AM
Chemotherapy; 1997; 43(6):424-9. PubMed ID: 9395856
[TBL] [Abstract][Full Text] [Related]
34. [Studies of correlative relations between virulence and other biological properties of Proteus].
Vitvits'kii VM; Dikii BM
Mikrobiol Zh; 1975; 37(6):748-51. PubMed ID: 1107766
[No Abstract] [Full Text] [Related]
35. Modulation of swarming and virulence by fatty acids through the RsbA protein in Proteus mirabilis.
Liaw SJ; Lai HC; Wang WB
Infect Immun; 2004 Dec; 72(12):6836-45. PubMed ID: 15557604
[TBL] [Abstract][Full Text] [Related]
36. Quantification of Urease Activity.
Richmond S; Yep A
Methods Mol Biol; 2019; 2021():85-96. PubMed ID: 31309498
[TBL] [Abstract][Full Text] [Related]
37. Complement activation by Proteus mirabilis negatively charged lipopolysaccharides.
Kaca W; Literacka E; Sjöholm AG; Weintraub A
J Endotoxin Res; 2000; 6(3):223-34. PubMed ID: 11052177
[TBL] [Abstract][Full Text] [Related]
38. Fimbriae of uropathogenic Proteus mirabilis.
Rocha SP; Pelayo JS; Elias WP
FEMS Immunol Med Microbiol; 2007 Oct; 51(1):1-7. PubMed ID: 17640292
[TBL] [Abstract][Full Text] [Related]
39. Potential virulence factors of Proteus bacilli.
Rózalski A; Sidorczyk Z; Kotełko K
Microbiol Mol Biol Rev; 1997 Mar; 61(1):65-89. PubMed ID: 9106365
[TBL] [Abstract][Full Text] [Related]
40. A novel autotransporter of uropathogenic Proteus mirabilis is both a cytotoxin and an agglutinin.
Alamuri P; Mobley HL
Mol Microbiol; 2008 May; 68(4):997-1017. PubMed ID: 18430084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
